Skip to main content
News > News > Jerome Hamilton, CEO of Open Therapeutics, Inc. is interviewed for Ignite2Disrupt by Chair of Global Connectivity

Jerome Hamilton, CEO of Open Therapeutics, Inc. is interviewed for Ignite2Disrupt by Chair of Global Connectivity

Recent interview with Jerome Hamilton, CEO of Open Therapeutics, Inc.for Ignite2Disrupt by Chair of Global Connectivity at the recent TiECon Midwest 2016 held in Dearborn, MI.

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.